Bradykinin and angiotensin II-induced [Ca2+]i rise in cultured rat pituitary folliculo-stellate cells

J Neuroendocrinol. 2001 Nov;13(11):942-50. doi: 10.1046/j.1365-2826.2001.00699.x.

Abstract

Folliculo-stellate cells of the anterior pituitary are thought to modulate pituitary hormone secretion through a paracrine mechanism. Angiotensin II and pituitary adenylate cyclase-activating polypeptide (PACAP) have previously been shown to increase the intracellular Ca2+ concentration ([Ca2+]i) of these cells. In the present study, we examined the effects of various peptides such as bradykinin, angiotensin II, endothelin-1, PACAP, galanin and neurotensin by Ca2+-imaging of folliculo-stellate cells in primary culture. Bradykinin and angiotensin II increased [Ca2+]i in folliculo-stellate cells. Both responses were completely suppressed by thapsigargin and were significantly suppressed by the phospholipase C inhibitor, U-73122. Ryanodine did not significantly modify the responses. A B2 antagonist and angiotensin II receptor antagonist inhibited the response induced by bradykinin and angiotensin II, respectively. Endothelin-1 and PACAP increased [Ca2+]i in fewer than 50% of folliculo-stellate cells but galanin and neurotensin did not influence [Ca2+]i in any of the folliculo-stellate cells tested. These results indicate that bradykinin and angiotensin II increase [Ca2+]i in folliculo-stellate cells by activating phospholipase C through B2 receptor and AT1 receptor, respectively, and that endothelin-1 and PACAP also increase [Ca2+]i in some folliculo-stellate cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II / pharmacology*
  • Animals
  • Bradykinin / pharmacology*
  • Caffeine / pharmacology
  • Calcium / metabolism*
  • Calcium / pharmacology
  • Cells, Cultured
  • Endothelin-1 / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Estrenes / pharmacology
  • Galanin / pharmacology
  • Male
  • Neuropeptides / pharmacology
  • Neurotensin / pharmacology
  • Phosphodiesterase Inhibitors / pharmacology
  • Pituitary Adenylate Cyclase-Activating Polypeptide
  • Pituitary Gland / cytology
  • Pituitary Gland / drug effects
  • Pituitary Gland / metabolism*
  • Pyrrolidinones / pharmacology
  • Rats
  • Rats, Wistar
  • Ryanodine / pharmacology
  • Thapsigargin / pharmacology
  • Type C Phospholipases / antagonists & inhibitors
  • Vasoconstrictor Agents / pharmacology*

Substances

  • Adcyap1 protein, rat
  • Endothelin-1
  • Enzyme Inhibitors
  • Estrenes
  • Neuropeptides
  • Phosphodiesterase Inhibitors
  • Pituitary Adenylate Cyclase-Activating Polypeptide
  • Pyrrolidinones
  • Vasoconstrictor Agents
  • Angiotensin II
  • 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione
  • U 73343
  • Ryanodine
  • Neurotensin
  • Caffeine
  • Thapsigargin
  • Galanin
  • Type C Phospholipases
  • Bradykinin
  • Calcium